Renke Bio

Renke Bio

人科生物

Renke Bio

Materials/Deep Tech

Renke Biotech has developed a fundamentally new approach to cancer genetic testing, using blood-based cfDNA open chromatin region detection for early screening of individual cancers and multiple cancer types. The method is simple to use and low-cost, addressing challenges such as the difficulty of…

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-09-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.